Nanoconstructs for the efficient delivery of siRNA molecules against Aquaporin-1 for anti-angiogenic therapies

被引：0
|
作者：
Stigliano, Cinzia [1 ]
Ananta, Jeyarama [1 ]
Acharya, Swetadrinadha [1 ]
Mackeyev, Yuri [2 ]
Wilson, Lon [2 ]
Nicchia, Grazia Paola [3 ]
Svelto, Maria [3 ]
Decuzzi, Paolo [1 ]
机构：
[1] Methodist Hosp, Res Inst, Houston, TX 77030 USA
[2] Rice Univ, Houston, TX USA
[3] Univ Bari, Bari, Italy
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2887
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2887
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Early clinical development of a novel anti-angiogenic monoclonal antibody directed against A5B1 integrin for treatment of solid tumors
    Finck, BK
    ANNALS OF ONCOLOGY, 2005, 16 : 27 - 28
  • [32] The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma
    Abou Faycal, Cherine
    Brambilla, Elisabeth
    Agorreta, Jackeline
    Lepeltier, Nina
    Jacquet, Thibault
    Lemaitre, Nicolas
    Emadali, Anouk
    Lucas, Anthony
    Lacal, Pedro M.
    Montuenga, Luis
    Pio, Ruben
    Gazzeri, Sylvie
    Eymin, Beatrice
    BRITISH JOURNAL OF CANCER, 2018, 118 (12) : 1596 - 1608
  • [33] The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma
    Cherine Abou Faycal
    Elisabeth Brambilla
    Jackeline Agorreta
    Nina Lepeltier
    Thibault Jacquet
    Nicolas Lemaître
    Anouk Emadali
    Anthony Lucas
    Pedro M Lacal
    Luis Montuenga
    Ruben Pio
    Sylvie Gazzeri
    Beatrice Eymin
    British Journal of Cancer, 2018, 118 : 1596 - 1608
  • [34] Anti-angiogenic mechanism of IPS-05002, a novel antagonist against integrin a5β1, determined by ProteoChip-based antibody array
    Min-A Kim
    In-Cheol Kang
    BioChip Journal, 2016, 10 : 174 - 181
  • [35] Novel anti-angiogenic gene therapy by cis-trans element decoy system against TNF-α induced SP-1 transactivation
    Ishibashi, H
    Nakagawa, K
    Onimaru, M
    Shirasuna, K
    Sueishi, K
    THROMBOSIS AND HAEMOSTASIS, 1999, : 520 - 520
  • [36] Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease
    Florence T. H. Wu
    Ping Xu
    Annabelle Chow
    Shan Man
    Janna Krüger
    Kabir A. Khan
    Marta Paez-Ribes
    Elizabeth Pham
    Robert S. Kerbel
    British Journal of Cancer, 2019, 120 : 196 - 206
  • [37] Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease
    Wu, Florence T. H.
    Xu, Ping
    Chow, Annabelle
    Man, Shan
    Krueger, Janna
    Khan, Kabir A.
    Paez-Ribes, Marta
    Pham, Elizabeth
    Kerbel, Robert S.
    BRITISH JOURNAL OF CANCER, 2019, 120 (02) : 196 - 206
  • [38] Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice
    Kim, Won Jong
    Yockman, James W.
    Jeong, Ji Hoon
    Christensen, Lane V.
    Lee, Minhyung
    Kim, Yong-Hee
    Kim, Sung Wan
    JOURNAL OF CONTROLLED RELEASE, 2006, 114 (03) : 381 - 388
  • [39] VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop
    Asma Boudria
    Cherine Abou Faycal
    Tao Jia
    Stephanie Gout
    Michelle Keramidas
    Chloé Didier
    Nicolas Lemaître
    Sandra Manet
    Jean-Luc Coll
    Anne-Claire Toffart
    Denis Moro-Sibilot
    Corinne Albiges-Rizo
    Véronique Josserand
    Eva Faurobert
    Christian Brambilla
    Elisabeth Brambilla
    Sylvie Gazzeri
    Beatrice Eymin
    Oncogene, 2019, 38 : 1050 - 1066
  • [40] VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop
    Boudria, Asma
    Abou Faycal, Cherine
    Jia, Tao
    Gout, Stephanie
    Keramidas, Michelle
    Didier, Chloe
    Lemaitre, Nicolas
    Manet, Sandra
    Coll, Jean-Luc
    Toffart, Anne-Claire
    Moro-Sibilot, Denis
    Albiges-Rizo, Corinne
    Josserand, Veronique
    Faurobert, Eva
    Brambilla, Christian
    Brambilla, Elisabeth
    Gazzeri, Sylvie
    Eymin, Beatrice
    ONCOGENE, 2019, 38 (07) : 1050 - 1066
12345